How to use social media in clinical trials - reaching out to patients
ASCO 2016 highlights for multiple myeloma
Changing the way we treat multiple myeloma based on biological markers in 2016
Why is personalized medicine important for CLL?
Are combination therapies more effective for the treatment of relapsed refractory CLL?